Refine by
Macular Degeneration Suppliers & Manufacturers
41 companies found
based inSouth San Francisco, CALIFORNIA (USA)
At UNITY we are developing therapeutics to slow, halt, or reverse diseases of aging. Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial ...
UBX1325, a potent Bcl-xL inhibitor, is in clinical development for the treatment of age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration (AMD), ...
based inMiami, FLORIDA (USA)
Heru is a spinoff company from the University of Miami’s Bascom Palmer Eye Institute. Bascom Palmer is ranked the number one eye hospital in the U.S., and where our AI diagnostics and vision augmentation platform is continuously developed. Our ...
Don’t let age-related macular degeneration (AMD) be your practice’s blind spot. Heru's Market-Leading AMD Portfolio. Heru’s AMD portfolio leverages contrast sensitivity & dark adaptation, which ...
based inShirley, NEW YORK (USA)
Profacgen is a state-of-the-art protein service provider located in Long Island, NY, USA. We provide custom protein services in the biological sciences, enabling access to the latest tools, techniques, and expertise with competitive pricing and ...
based inManassas, VIRGINIA (USA)
Notal Vision is the first diagnostic services company to extend eye disease management from the clinic to the home and improve vision outcomes. By applying artificial intelligence (AI)-driven data interpretation to the unprecedented high volumes of ...
Notal Vision is developing a first-of-its-kind Artificial Intelligence-enabled digital diagnostic for patients with neovascular retina diseases using our patient-operated Home Optical Coherence Tomography device. The first disease in the Notal Home ...
based inParis, FRANCE
Pixium Vision, created in December 2011, is a bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling ...
Treatment for blindness represents a major unmet medical need throughout the world, including Europe and the United States. In 2010, there were about 285 million visually impaired people worldwide and around 39 million were totally ...
based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
Induced pluripotent stem cells (iPSCs) are established by introducing several factors to somatic cells such as skin cells. iPSCs can differentiate into the cells of a various tissues or organs (pluripotency) and grow indefinitely (proliferation). ...
based inMiddletown, PENNSYLVANIA (USA)
MacuLogix is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage age-related macular degeneration (AMD) patients early, before irreversible vision loss has occurred. We can help ...
Backed by 20 years of proven clinical research, the AdaptDx Pro® is a revolutionary new way to test patients. Advanced, precision eye tracking technology automatically aligns with the eye to capture an accurate measurement of dark adaptation ...
based inYuseong-gu, SOUTH KOREA
We strive to become a leading biotech company that contributes to human health and well-being by providing innovative therapeutic antibodies to patients with unmet medical needs. We have been committed to developing novel antibody therapeutics since ...
PMC-403 is a monoclonal antibody that targets the human TIE2 that regulate the angiogenesis and vessel maturation in endothelial cells. It binds to TIE2 expressing endothelial cells and normalize VEGF-induced pathological leaky blood vessels in eyes ...
based inHamburg, GERMANY
3B Scientific was founded in 1948 in Hamburg, Germany and has grown to be one of the world's leading manufacturers of Medical and Science Education solutions. The product portfolio covers a complete and comprehensive range of equipment for ...
This human eye model by 3B Scientific® shows an eye enlarged by a factor of 5. It is a perfect tool to assists the healthcare professional in educating patients in the anatomy and changes of the human ...
based inWaltham, MASSACHUSETTS (USA)
Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases. Existing therapies for retinal neovascular / exudative diseases have made great ...
With high affinity for VEGF and heparan sulfate proteoglycans, TH103 potentially increases intraocular retention, thereby minimizing injection frequency. Ongoing Phase 1 clinical trials for neovascular age-related macular ...
based inTucson, ARIZONA (USA)
Salutaris Medical Devices (SMD) is a clinical-stage medical device company specializing in the treatment of ophthalmic diseases with a precision beta radiotherapy delivery platform. Our globally-patented, 510k-cleared device has the potential to ...
Anti-VEGF Resistant Disease; 20+ million seniors suffer vision loss from wet-AMD (advanced age-related macular degeneration). The current treatment for wet-AMD is frequent (sometimes monthly) injections of anti-VEGF ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Reproxalap (ADX-102) is an active aldehyde sequestering agent that's being researched for dry eye syndrome, allergic conjunctivitis, and non-infectious anterior uveitis. Reproxalap has anti-inflammatory and pain-relieving ...
based inBellshill, UNITED KINGDOM
Since Andersen Caledonia’s origin in 1997 we have continuously advanced the methods used for infection prevention and contamination control to combat the ever-evolving microbiological and environmental challenges faced by our customers. Our ...
SP.eye™ is a single device integrating a delivery guide, 30 gauge needle and sharps safe system to assist in the delivery of intravitreal injections. Developed by Ophthalmologists with extensive experience in intravitreal injection ...
based inGaithersburg, MARYLAND (USA)
Otomagnetics, a University of Maryland College Park spin-out, is developing a non-invasive method to deliver drugs and other therapeutic payloads to inner and middle ear compartments, to the eye, and into the skin. The inner ear is behind the ...
Otomagnetics is developing and commercializing a magnetic injection delivery system that will be able to safely, effectively, and non-invasively deliver therapy to targets in the body that are currently not effectively reached by the ...
based inCarlsbad, CALIFORNIA (USA)
Our mission is to pioneer a new branch of medicine based on transplanting specific cell types to patients with serious medical conditions. Lineage’s programs are based on the Company’s proprietary cell-based therapy platform and associated ...
On December 20, 2021, Lineage announced that it has entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the treatment ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
based inMalvern, PENNSYLVANIA (USA)
Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19. Our breakthrough modifier gene therapy platform ...
OCU200 is a biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Wet Age-Related Macular ...
based inCournon d`Auvergne, FRANCE
Quantel Medical is a fully owned subsidiary of the Lumibird Group. Its core activities are the development, manufacturing and commercialization of innovative solutions in medical lasers and ultrasound ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...
based inAichi, JAPAN
Nidek offers a wide array of equipment designed for the diagnosis and treatment of retinal diseases, glaucoma, and other vision-impairing afflictions. Our aim is to avail the field with products of unmatched quality, service, and value. Since its ...
